Camlin Fine Sciences share price

High risk
  • 61%Low risk
  • 61%Moderate risk
  • 61%Balanced risk
  • 61%High risk
  • 61%Extreme risk
  • 185.70(-4.18%)
    May 23, 2025 14:17:42 PM IST
    • NSE
    • BSE
  • Vol : 569.70K (NSE + BSE)
    Last 20 day avg : 1.51 M

Camlin Fine Sciences is trading -4.18% lower at Rs 185.70 as compared to its last closing price. Camlin Fine Sciences has been trading in the price range of 195.45 & 185.05. Camlin Fine Sciences has given 51.57% in this year & -1.55% in the last 5 days. There are 2 analysts who have initiated coverage on Camlin Fine Sciences. There are 0.00 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -4.14 Crores in its last quarter.Listed peers of Camlin Fine Sciences include Kiri Industries (1.95%), Rossari Biotech (0.33%), Camlin Fine Sciences (-4.18%).The Mutual Fund holding in Camlin Fine Sciences was at 3.48% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Camlin Fine Sciences was at 1.47% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on May 23, 2025, 08:47 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.85
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.51
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.79
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
185.05
Highest
195.45
52 week range
Lowest
78.15
Highest
204.85
Camlin Fine Sciences Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue grew in December quarter by 12.34% from Rs 433.49 crore to Rs 385.89 crore, year-on-year
    • financial-insightsThe company has reduced its December quarter loss by 64.90% from Rs 11.79 crore to Rs 4.14 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Camlin Fine Sciences Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 195.18
  • R2
  • 228.02
  • R3
  • 251.18
Pivot172.02
  • S1
  • 139.18
  • S2
  • 116.02
  • S3
  • 83.18
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Camlin Fine Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Kiri Industries
Bullish
665.701.953,723.3325.911.23-0.85
Rossari Biotech
Bearish
658.500.333,645.7126.643.060.0810.32
Camlin Fine Sciences
Bullish
185.70-4.183,497.86-3.82-40.46
Vishnu Chemicals
Bullish
495.90-1.193,338.1725.753.60.0617.20
Premier Explosives
Bullish
546.65-9.992,938.86110.7314.270.095.68
Camlin Fine Sciences Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Camlin Fine Sciences is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 10.84% of shares.
    • InsightsPledging Flat - Promoter(s) pledging has not increased in last quarter.
    • InsightsPromoter(s) holding is moderate at 49.10%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.65 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.58 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    JM Small Cap Fund Regular Growth
    NA
    • Amount Invested (Cr.) 11.89
    • % of AUM 1.88
    JM Aggressive Hybrid Fund Growth
    4/5
    • Amount Invested (Cr.) 13.77
    • % of AUM 1.72
    ICICI Prudential Commodities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 24.43
    • % of AUM 0.93
    ICICI Prudential Smallcap Fund Institutional Growth
    3/5
    • Amount Invested (Cr.) 44.65
    • % of AUM 0.59
    ICICI Prudential Smallcap Fund Growth
    3/5
    • Amount Invested (Cr.) 44.65
    • % of AUM 0.59
    Camlin Fine Sciences Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-23Audited Results
    2025-02-14Quarterly Results
    2025-01-02Others
    2024-11-22Rights issue of Equity Shares
    2024-11-11Quarterly Results
    About the company Camlin Fine Sciences
    • IndustryChemical Manufacturing
    • ISININE052I01032
    • BSE Code532834
    • NSE CodeCAMLINFINE
    Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. The Company’s products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care.
    • Management Info
    • Ashish DandekarChairman of the Board, Managing Director
    • Santosh ParabChief Financial Officer
    • Nilesh JadhavChief Operating Officer
    • Rahul SawaleChief Compliance Officer, Vice President - Legal, Company Secretary
    • Nirmal MomayaManaging Director
    • Arjun DukaneExecutive Director - Technical
    Camlin Fine Sciences Share Price FAQs

    Camlin Fine Sciences is trading at 185.70 as on Fri May 23 2025 08:47:42. This is -4.18% lower as compared to its previous closing price of 193.80.

    The market capitalization of Camlin Fine Sciences is 3497.86 Cr as on Fri May 23 2025 08:47:42.

    The average broker rating on Camlin Fine Sciences is Buy. The breakup of analyst rating is given below -

    • 0.00 analysts have given a strong buy rating
    • 2 analysts have given a buy rating
    • 0.00 analysts have given a hold rating
    • 0.00 analysts have given a sell rating
    • 0.00 analysts have given a strong sell rating

    The 52 wk high for Camlin Fine Sciences is 204.85 whereas the 52 wk low is 78.15

    Camlin Fine Sciences can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 17.45
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Camlin Fine Sciences reported a net profit of -92.75 Cr in 2024.

    The Mutual Fund Shareholding was 3.48% at the end of 31 Mar 2025.